BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35470438)

  • 1. Perceived utility of electrodiagnostic testing in critical illness myopathy and polyneuropathy: A survey of intensive care unit providers.
    Isfort M; McVerry BJ; Shutter L; Kim M; Lacomis D
    Muscle Nerve; 2022 Jul; 66(1):90-95. PubMed ID: 35470438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical illness myopathy and neuropathy.
    Latronico N; Guarneri B
    Minerva Anestesiol; 2008 Jun; 74(6):319-23. PubMed ID: 18500207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrodiagnostic studies in the intensive care unit: A comparison study 2 decades later.
    Ojha A; Zivkovic SA; Lacomis D
    Muscle Nerve; 2018 May; 57(5):772-776. PubMed ID: 29053882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term recovery In critical illness myopathy is complete, contrary to polyneuropathy.
    Koch S; Wollersheim T; Bierbrauer J; Haas K; Mörgeli R; Deja M; Spies CD; Spuler S; Krebs M; Weber-Carstens S
    Muscle Nerve; 2014 Sep; 50(3):431-6. PubMed ID: 24415656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurophysiological study of critical illness polyneuropathy and myopathy in mechanically ventilated children; additional aspects in paediatric critical illness comorbidities.
    Thabet Mahmoud A; Tawfik MAM; Abd El Naby SA; Abo El Fotoh WMM; Saleh NY; Abd El Hady NMS
    Eur J Neurol; 2018 Jul; 25(7):991-e76. PubMed ID: 29604150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge.
    Koch S; Spuler S; Deja M; Bierbrauer J; Dimroth A; Behse F; Spies CD; Wernecke KD; Weber-Carstens S
    J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):287-93. PubMed ID: 20802220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular disorders in critically ill patients: review and update.
    Lacomis D
    J Clin Neuromuscul Dis; 2011 Jun; 12(4):197-218. PubMed ID: 22361518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and neurophysiological characterization of muscular weakness in severe COVID-19.
    Bax F; Lettieri C; Marini A; Pellitteri G; Surcinelli A; Valente M; Budai R; Patruno V; Gigli GL
    Neurol Sci; 2021 Jun; 42(6):2173-2178. PubMed ID: 33755815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for preventing critical illness polyneuropathy and critical illness myopathy.
    Hermans G; De Jonghe B; Bruyninckx F; Van den Berghe G
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD006832. PubMed ID: 24477672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical illness polyneuropathy and myopathy in a rural area in Vietnam.
    Nguyen The L; Nguyen Huu C
    J Neurol Sci; 2015 Oct; 357(1-2):276-81. PubMed ID: 26276515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive care unit-acquired weakness: unanswered questions and targets for future research.
    Piva S; Fagoni N; Latronico N
    F1000Res; 2019; 8():. PubMed ID: 31069055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery and long term functional outcome in people with critical illness polyneuropathy and myopathy: a scoping review.
    Intiso D; Centra AM; Bartolo M; Gatta MT; Gravina M; Di Rienzo F
    BMC Neurol; 2022 Feb; 22(1):50. PubMed ID: 35148710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome, predictors and longitudinal trajectories of subjects with critical illness polyneuropathy and myopathy (CINAMOPS): study protocol of an observational cohort study in a clinical and post-clinical setting.
    Bergmann J; Egger M; Müller F; Jahn K
    BMJ Open; 2024 Apr; 14(4):e083553. PubMed ID: 38670603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term neuromuscular sequelae of critical illness.
    Semmler A; Okulla T; Kaiser M; Seifert B; Heneka MT
    J Neurol; 2013 Jan; 260(1):151-7. PubMed ID: 22820684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical review: Critical illness polyneuropathy and myopathy.
    Hermans G; De Jonghe B; Bruyninckx F; Van den Berghe G
    Crit Care; 2008; 12(6):238. PubMed ID: 19040777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for preventing critical illness polyneuropathy and critical illness myopathy.
    Hermans G; De Jonghe B; Bruyninckx F; Van den Berghe G
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006832. PubMed ID: 19160304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis.
    Latronico N; Bolton CF
    Lancet Neurol; 2011 Oct; 10(10):931-41. PubMed ID: 21939902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study.
    Guarneri B; Bertolini G; Latronico N
    J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):838-41. PubMed ID: 18339730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy].
    Judemann K; Lunz D; Zausig YA; Graf BM; Zink W
    Anaesthesist; 2011 Oct; 60(10):887-901. PubMed ID: 22006117
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.